Jingwen Wu

Jingwen Wu

Auto-generated profile, based on publicly available information

Jingwen Wu

Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, No. 29 Zhongguancun East Road, Beijing 100190, P. R. China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2018 in Journal of Biomaterials Applications
Verified
Journal Article
Closed access
JWJingwen Wu
Jingwen Wu
GMGuohou Miao
Guohou Miao
ZZZhichao Zheng
Zhichao Zheng
ZLZhengmao Li
Zhengmao Li
WRWen Ren
Wen Ren
LGLvhua Guo
Lvhua Guo
Drug delivery and release are a major challenge fabricating bone tissue engineering. In this study, we fabricated new sustained release hydrogel scaffolds composited of mesoporous bioactive glass, sodium alginate and gelatin by a three-dimensional printing technique. Naringin and calcitonin gene-related peptide were used as drugs to prepare drug-loaded scaffolds by direct printing or surface absorption. The physicochemical properties of the scaffolds and the drug release profiles of the two drug-loading models were investigated. We also examined the biocompatibility of the scaffolds, as well as the effect of the released medium on the proliferation and osteogenic differentiation of human osteoblast-like MG-63 cell. The results showed that the scaffolds had a high porosity (approximately 80%) with an interconnected cubic pore structure, rough surface morphology, bioactivity and strong biocompatibility. Furthermore, the naringin or calcitonin gene-related peptide co-printed into the scaffold displayed a steady sustained release behaviour for up to 21 days without an initial burst release, while both naringin and calcitonin gene-related peptide absorbed onto the surface of the scaffold were completely released within two days. MG-63 cells cultured with the extraction containing released drugs displayed promoted cell proliferation and the expression of osteogenesis-related genes more effectively compared with the drug-free extractions. Therefore, these results demonstrate that the developed mesoporous bioactive glass/sodium alginate/gelatin sustained release scaffolds provide a potential application for bone tissue engineering.

22 May 2024 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
JWJingwen Wu
Jingwen Wu
FYFenglin Yu
Fenglin Yu
MSMingfei Shao
Mingfei Shao
TZTong Zhang
Tong Zhang
WLWeipeng Lu
Weipeng Lu
YGYanchuan Guo
Yanchuan Guo

7 May 2024 in ACS Applied Nano Materials
Verified
Journal Article
Closed access
JWJingwen Wu
Jingwen Wu
RXRui Xu
Rui Xu
MSMingfei Shao
Mingfei Shao
LZLaixi Zhao
Laixi Zhao
WXWenhua Xu
Wenhua Xu
YGYanchuan Guo
Yanchuan Guo

23 February 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
JWJingwen Wu
Jingwen Wu
HWHongjiang Wei
Hongjiang Wei
YWYan Wei
Yan Wei
TDTian Deng
Tian Deng
YWYulan Wang
Yulan Wang
YZYufeng Zhang
Yufeng Zhang

27 March 2023 in Journal of Biomaterials Applications
Verified
Journal Article
Closed access
XTXinran Tu
Xinran Tu
LGLiyang Guo
Liyang Guo
YLYang Li
Yang Li
GTGuozhong Tan
Guozhong Tan
RCRongfeng Chen
Rongfeng Chen
QJQianzhou Jiang
Qianzhou Jiang
Three-dimensional (3D)-printed scaffolds are a new strategy to fabricate biomaterials for treating bone defects. Here, using a 3D-printing technique, we fabricated scaffolds consisting of gelatin (Gel), sodium alginate (SA), and 58S bioactive glass (58S BG). To evaluate mechanical properties and biocompatibility of Gel/SA/58S BG scaffolds, the degradation test, compressive strength test, and cytotoxicity test were performed. The effect of the scaffolds on cell proliferation in vitro was determined by 4′,6-diamidino-2-phenylindole (DAPI) staining. To evaluate osteoinductive properties, rBMSCs were cultured on the scaffolds for 7, 14, and 21 days and the expression of osteogenesis-related genes was analyzed using qRT-PCR. To examine the bone healing properties of Gel/SA/58S BG scaffolds in vivo, we used a rat mandibular critical-size defect bone model. The scaffolds were implanted into the defect area of rat mandible and bone regeneration and new tissue formation were assessed using microcomputed tomography (microCT) and hematoxylin and eosin (H&E) staining. The results showed that Gel/SA/58S BG scaffolds had appropriate mechanical strength as a filling material for bone defects. Furthermore, the scaffolds could be compressed within certain limits and then could recover their shape. The extract of the Gel/SA/58S BG scaffold showed no cytotoxicity. In vitro, the expression levels of Bmp2, Runx2, and OCN were increased in rBMSCs cultured on the scaffolds. In vivo, microCT and H&E staining demonstrated that scaffolds induced the formation of new bone at the mandibular defect area. These results indicated that Gel/SA/58S BG scaffolds have excellent mechanical characteristics, biocompatibility, and osteoinductive properties, suggesting that it could be a promising biomaterial for the repair of bone defects.

14 January 2026 in Materials Futures
Verified
Journal Article
Open access
XCXin Chen
Xin Chen
TZTong Zhang
Tong Zhang
HLHanfeng Li
Hanfeng Li
YCYu Chen
Yu Chen
BZBing Zhang
Bing Zhang
JWJingwen Wu
Jingwen Wu
The repair of critical-sized bone defects remains a significant challenge in regenerative medicine. Using guided bone regeneration (GBR) membranes has emerged as a promising treatment strategy. In this study, we fabricate a novel multilayer density-gradient electrospun nanofiber membrane comprising bone morphogenetic protein-2 (BMP-2) combined with nano-hydroxyapatite (nHA) and vascular endothelial growth factor (VEGF) embedded in a polylactic acid (PLA) and type I collagen (COL) nanofiber matrix, denoted as BMP-2@nHA/VEGF@(PLA/COL). The gradient density structure of membranes is engineered to mimic the periosteum tissue, thereby creating an optimal microenvironment for bone regeneration while preventing soft tissue invasion. The membrane exhibits commendable mechanical properties and favorable degradation characteristics. Drug release experiments reveal that the membrane enables an early-phase release of VEGF, coupled with a prolonged release of BMP-2, advantageous for fostering early vascularization and long-term osteogenesis. In vitro studies confirm that the membrane effectively maintains barrier function while enhancing the coordinated advancement of both vascularization and osteogenesis. Furthermore, experiments with a rat cranial bone defect model demonstrate that the membrane substantially accelerates bone regeneration. Consequently, the bionic membrane developed in this research shows considerable potential for clinical applications in GBR therapies.